These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19879695)

  • 1. Overcoming multidrug-resistance in cancer: statins offer a logical candidate.
    Mehta NG; Mehta M
    Med Hypotheses; 2010 Feb; 74(2):237-9. PubMed ID: 19879695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can flavonoids from honey alter multidrug resistance?
    Jaganathan SK
    Med Hypotheses; 2011 Apr; 76(4):535-7. PubMed ID: 21247706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.
    Liu FS
    Taiwan J Obstet Gynecol; 2009 Sep; 48(3):239-44. PubMed ID: 19797012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM
    Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications].
    Petraccia L; Onori P; Sferra R; Lucchetta MC; Liberati G; Grassi M; Gaudio E
    Clin Ter; 2003; 154(5):325-35. PubMed ID: 14994922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
    Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
    Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in cancer: its mechanism and its modulation.
    Pauwels EK; Erba P; Mariani G; Gomes CM
    Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
    Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
    Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates.
    Zloh M; Kaatz GW; Gibbons S
    Bioorg Med Chem Lett; 2004 Feb; 14(4):881-5. PubMed ID: 15012986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
    Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
    Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis.
    Wong WW; Dimitroulakos J; Minden MD; Penn LZ
    Leukemia; 2002 Apr; 16(4):508-19. PubMed ID: 11960327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and cancer: current and future prospects.
    Osmak M
    Cancer Lett; 2012 Nov; 324(1):1-12. PubMed ID: 22542807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different strategies to overcome multidrug resistance in cancer.
    Saraswathy M; Gong S
    Biotechnol Adv; 2013 Dec; 31(8):1397-407. PubMed ID: 23800690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
    Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
    Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and strategies to overcome multiple drug resistance in cancer.
    Ozben T
    FEBS Lett; 2006 May; 580(12):2903-9. PubMed ID: 16497299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins, autophagy and cancer metastasis.
    Zhang J; Yang Z; Xie L; Xu L; Xu D; Liu X
    Int J Biochem Cell Biol; 2013 Mar; 45(3):745-52. PubMed ID: 23147595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-derived microvesicles and antitumoral multidrug resistance.
    Tatischeff I
    C R Biol; 2012 Feb; 335(2):103-6. PubMed ID: 22325563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.